Montascend 10 mg Tablet
PDF Leaflet Revision Date: 20 June 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis and chronic treatment of atopic asthma in adults and children 15 years and older.
Dosage (summary)
One tablet (10 mg) daily in the evening for adults and children 15 years and older.
Onset of Action / Duration
Onset: 1 day, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established; avoid breastfeeding.
Key Drug Interactions
- Theophylline
- Prednisone
- Warfarin
- Gemfibrozil
Contraindications
- Hypersensitivity to montelukast
- Children under 15 years
Common side effects
- Headache
- Dizziness
- Upper respiratory tract infections
- Rash
Counselling Points
- Continue taking even when asymptomatic.
- Have rescue medication available for acute attacks.
- Notify healthcare provider of neuropsychiatric events.
- Avoid aspirin if sensitive.
Serious warnings
- Not for acute asthma attacks
- Risk of neuropsychiatric events
- Churg-Strauss syndrome
Important Disclaimer
The Montascend 10 mg Tablet professional information leaflet below is the property of Ascend Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
